Abstract
Propofol and midazolam have a synergistic anesthetic action. One of the reasons for this is thought to be the inhibitory effect of propofol on midazolam metabolism. However, because both drugs bind strongly to serum protein, their interaction may not only involve the effects of propofol on midazolam metabolism, but may also involve propofol’s effects on serum protein-binding. Against this background, we investigated the characteristics of midazolam binding to serum albumin, and evaluated the effects of both propofol and ketamine on this binding. Midazolam was added to a serum albumin solution with propofol or ketamine, and, after incubation for 1 h, albumin-free solution was separated from the sample and the midazolam concentration was measured using a high-performance liquid chromatography system. The albumin-unbound rate of midazolam was evaluated and compared with the rate in the control solution (only midazolam). Propofol significantly raised the rate of albumin-unbound free midazolam, while ketamine had no effect on the binding of midazolam to serum albumin. These findings suggest that the increase in albumin-unbound free midazolam brought about by propofol is involved in the synergistic effect of these two agents.
This is a preview of subscription content, log in via an institution to check access.
References
Cote CJ, Karl HW, Notterman DA, Weinberg JA, McCloskey C. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics. 2000;106:633–44.
Short TG, Chui PT. Propofol and midazolam act synergistically in combination. Br J Anaesth. 1991;67:539–45.
McClune S, McKay AC, Wright PMC, Patterson CC, Clarke SJ. Synergistic interaction between midazolam and propofol. Br J Anaesth. 1992;69:240–5.
Paspatis GA, Manolaraki M, Xirouchakis G, Papanikolaou N, Chlouverakis G, Gritzali A. Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study. Am J Gastroenterol. 2002;97:1963–7.
Hamaoka N, Oda Y, Hase I, Mizutani K, Nakamoto T, Ishizaki T, Asada A. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study. Clin Pharmacol Ther. 1999;66:110–7.
Dundee JW. New I.V. anesthetics. Br J Anaesth. 1979;51:641–8.
Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology. 1984;61:27–35.
Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth. 1988;60:146–50.
Reves JG, Newfield P, Smith LR. Influence of serum protein, serum albumin concentrations and dose on midazolam anaesthesia induction times. Can Anaesth Soc J. 1981;28:556–60.
Muller W, Wollert U. Characterization of the binding of benzodiazepines to human serum albumin. Naunyn Schmiedeberg’s Arch Pharmacol. 1973;280:229–37.
Dayton PG, Stiller RL, Cook DR, Perel JM. The binding of ketamine to plasma proteins: emphasis on human plasma. Eur J Clin Pharmacol. 1983;24:825–31.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ohmori, J., Maeda, S., Higuchi, H. et al. Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution. J Anesth 25, 618–620 (2011). https://doi.org/10.1007/s00540-011-1176-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-011-1176-6